Fangfei Li
Impact in
Papers in
- Oncology 17
- Cancer Immunotherapy and Biomarkers 3
- Metal complexes synthesis and properties 3
-
- Parkinson's Disease Mechanisms and Treatments 5
- Neurological disorders and treatments 4
- Botulinum Toxin and Related Neurological Disorders 2
- Co-authors
- F. Richard Keene (3 shared papers)J. Grant Collins (3 shared papers)Ge Zhang (8 shared papers)Aiping Lü (11 shared papers)Tao Feng (3 shared papers)Shun Yu (1 shared paper)Xuemei Wang (1 shared paper)Xiaoqiu Wu (4 shared papers)
- Journals
- International Journal of Molecular Sciences (4 papers)Cancer Research (2 papers)Foods (2 papers)Frontiers in Cell and Developmental Biology (2 papers)International Journal of Biological Sciences (2 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Fangfei Li
39 papers receiving 1.3k citations
Fangfei Li's Hit Papers
Peers
Comparison fields: 5 of 115
- Oncology 460
- Neurology 153
- Organic Chemistry 276
- Cancer Research 107
- Molecular Biology 401
Countries citing papers authored by Fangfei Li
This map shows the geographic impact of Fangfei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangfei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangfei Li more than expected).
Fields of papers citing papers by Fangfei Li
This network shows the impact of papers produced by Fangfei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangfei Li. The network helps show where Fangfei Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Fangfei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 404 | |
| 2 | 2015 | 129 | |
| 3 | 2016 | 128 | |
| 4 | Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation Hit paper breakdown → | 2023 | 125 |
| 5 | 2017 | 77 | |
| 6 | 2020 | 72 | |
| 7 | 2020 | 52 | |
| 8 | 2022 | 39 | |
| 9 | 2019 | 39 | |
| 10 | 2019 | 29 | |
| 11 | 2016 | 28 | |
| 12 | 2022 | 28 | |
| 13 | 2021 | 26 | |
| 14 | 2015 | 19 | |
| 15 | 2025 | 18 | |
| 16 | 2014 | 17 | |
| 17 | 2022 | 16 | |
| 18 | 2022 | 15 | |
| 19 | 2022 | 13 | |
| 20 | 2021 | 12 |
About Fangfei Li
Fangfei Li is a scholar working on Oncology, Neurology, Immunology, Molecular Biology and Cancer Research, having authored 41 papers that have together received 1.4k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (5 papers), Neurological disorders and treatments (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Metal complexes synthesis and properties (3 papers), Immune cells in cancer (2 papers), Immunotherapy and Immune Responses (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). The work is most often cited by research in Oncology (460 citations), Neurology (153 citations), Organic Chemistry (276 citations), Cancer Research (107 citations) and Molecular Biology (401 citations). Fangfei Li has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include F. Richard Keene, J. Grant Collins, Ge Zhang, Aiping Lü, Tao Feng, Shun Yu, Xuemei Wang, Xiaoqiu Wu, Chao Liang and Feng Jiang. Their work appears in journals such as International Journal of Molecular Sciences, Cancer Research, Foods, Frontiers in Cell and Developmental Biology and International Journal of Biological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.